Targeting Chemoprophylaxis in Venous Thromboembolism Using Biomarker Guidance.
Publication
, Journal Article
Cutrone, MH; Welsby, IJ; Ghadimi, K
Published in: JAMA Surg
February 1, 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Surg
DOI
EISSN
2168-6262
Publication Date
February 1, 2023
Volume
158
Issue
2
Start / End Page
220 / 221
Location
United States
Related Subject Headings
- Venous Thromboembolism
- Risk Factors
- Retrospective Studies
- Postoperative Complications
- Humans
- Chemoprevention
- Anticoagulants
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Cutrone, M. H., Welsby, I. J., & Ghadimi, K. (2023). Targeting Chemoprophylaxis in Venous Thromboembolism Using Biomarker Guidance. JAMA Surg, 158(2), 220–221. https://doi.org/10.1001/jamasurg.2022.5333
Cutrone, Michael H., Ian J. Welsby, and Kamrouz Ghadimi. “Targeting Chemoprophylaxis in Venous Thromboembolism Using Biomarker Guidance.” JAMA Surg 158, no. 2 (February 1, 2023): 220–21. https://doi.org/10.1001/jamasurg.2022.5333.
Cutrone MH, Welsby IJ, Ghadimi K. Targeting Chemoprophylaxis in Venous Thromboembolism Using Biomarker Guidance. JAMA Surg. 2023 Feb 1;158(2):220–1.
Cutrone, Michael H., et al. “Targeting Chemoprophylaxis in Venous Thromboembolism Using Biomarker Guidance.” JAMA Surg, vol. 158, no. 2, Feb. 2023, pp. 220–21. Pubmed, doi:10.1001/jamasurg.2022.5333.
Cutrone MH, Welsby IJ, Ghadimi K. Targeting Chemoprophylaxis in Venous Thromboembolism Using Biomarker Guidance. JAMA Surg. 2023 Feb 1;158(2):220–221.
Published In
JAMA Surg
DOI
EISSN
2168-6262
Publication Date
February 1, 2023
Volume
158
Issue
2
Start / End Page
220 / 221
Location
United States
Related Subject Headings
- Venous Thromboembolism
- Risk Factors
- Retrospective Studies
- Postoperative Complications
- Humans
- Chemoprevention
- Anticoagulants
- 3202 Clinical sciences